BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: O’Connor A, McNamara D, O’Moráin CA. Surveillance of gastric intestinal metaplasia for the prevention of gastric cancer. Cochrane Database Syst Rev. 2013;9:CD009322. [PMID: 24062262 DOI: 10.1002/14651858.cd009322.pub2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
Number Citing Articles
1 Liu KSH, Wong IOL, Leung WK. Helicobacter pylori associated gastric intestinal metaplasia: Treatment and surveillance. World J Gastroenterol 2016; 22(3): 1311-1320 [PMID: 26811668 DOI: 10.3748/wjg.v22.i3.1311] [Cited by in CrossRef: 37] [Cited by in F6Publishing: 30] [Article Influence: 6.2] [Reference Citation Analysis]
2 Gibson V, Needham S, Nayer M, Thompson NP. Do non-targeted gastric biopsies affect the management of patients, and can a simple protocol and education reduce the rate? Frontline Gastroenterol 2018;9:67-72. [PMID: 29484163 DOI: 10.1136/flgastro-2017-100813] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
3 Alam W, Ullah H, Santarcangelo C, Di Minno A, Khan H, Daglia M, Arciola CR. Micronutrient Food Supplements in Patients with Gastro-Intestinal and Hepatic Cancers. Int J Mol Sci 2021;22:8014. [PMID: 34360782 DOI: 10.3390/ijms22158014] [Reference Citation Analysis]
4 Altayar O, Davitkov P, Shah SC, Gawron AJ, Morgan DR, Turner K, Mustafa RA. AGA Technical Review on Gastric Intestinal Metaplasia-Epidemiology and Risk Factors. Gastroenterology 2020;158:732-744.e16. [PMID: 31816301 DOI: 10.1053/j.gastro.2019.12.002] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 7.3] [Reference Citation Analysis]
5 Chen BJ, Zeng S, Xie R, Hu CJ, Wang SM, Wu YY, Xiao YF, Yang SM. hTERT promotes gastric intestinal metaplasia by upregulating CDX2 via NF-κB signaling pathway. Oncotarget 2017;8:26969-78. [PMID: 28460480 DOI: 10.18632/oncotarget.15926] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
6 Chin JL, O'Toole D. Diagnosis and Management of Upper Gastrointestinal Neuroendocrine Tumors. Clin Endosc. 2017;50:520-529. [PMID: 29207862 DOI: 10.5946/ce.2017.181] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
7 Akbari M, Tabrizi R, Kardeh S, Lankarani KB. Gastric cancer in patients with gastric atrophy and intestinal metaplasia: A systematic review and meta-analysis. PLoS One 2019;14:e0219865. [PMID: 31348819 DOI: 10.1371/journal.pone.0219865] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]